Poor lipid control in type-2 diabetics with and without ischemic heart disease

King Abdulaziz University, Djidda, Makkah, Saudi Arabia
Endocrine (Impact Factor: 3.53). 08/2003; 21(3):217-20. DOI: 10.1385/ENDO:21:3:217
Source: PubMed

ABSTRACT To determine the frequency of type-2 diabetics who have target lipoprotein blood levels, to study these levels in patients with ischemic heart disease and cardiovascular disease risk factors, and to study the possible causes of poor control, we reviewed hyperlipdemic type-2 diabetics who were on regular follow up to the medical outpatient clinic of King Abdulaziz University Hospital from January 2000 to January 2001. A total of 202 patients were studied with mean age of 60 yr and equal male to female ratio. The mean duration of diabetes was 10 yr and it was 7 yr for hyperlipidemia. The mean level of LDL was 3.15 mmol/L and it was 1.0 mmol/L and 2.47 mmol/L for HDL and TG, respectively. Only 31% of patients had LDL < 2.6 mmol/L, 28% had HDL > 1.1 mmol/L, and 37% had TG < 1.7 mmol/L. No significant difference was found in the frequency of target level of LDL in patients with IHD and those without; 26% vs 34% (0.4). Similarly, no difference was found in those with hypertension, obesity, and patients with family history of IHD compared to those without these risk factors; 30%, 26%, 16% vs 34%, 36%, 33% (p = 0.2, 0.1, 0.4, respectively). Males were found to have a higher frequency of target LDL level compared to females; 38% vs 25% (p = 0.04). Poor diet restriction was found in 90% of patients' with poor control, lack of patients' knowledge in 62%, 70% have financial reasons, 86% of patients on multiple medications, and in 16% the treating physician took no proper action. In conclusion, a low frequency of type-2 diabetics have target levels of lipoproteins. Diabetics with IHD and CVD risk factors also have poor lipid control. Poor control was associated with poor diet compliance and use of multiple medications. Proper management and control of this disease is needed among elderly patients.

Download full-text


Available from: Daad H Akbar, Jul 06, 2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: Low-density parity-check (LDPC) codes are one of the most promising next generation error correcting codes and many investigations shows that LDPC codes suitable for many hardware implementation. Although randomly constructed LDPC codes are usually encoded by using generator matrix, this method requires quadratic time complexity and is not easy to implement. This work presents the encoding of array-type LDPC codes and a special class of Sridhara-Fuja-Tanner (SFT) codes by division circuits as cyclic codes, which are very easy to implement.
    Information Theory, 2004. ISIT 2004. Proceedings. International Symposium on; 08/2004
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Excess lipid accumulation in the heart is associated with decreased cardiac function in humans and in animal models. The reasons are unclear, but this is generally believed to result from either toxic effects of intracellular lipids or excessive fatty acid oxidation (FAO). PPARγ expression is increased in the hearts of humans with metabolic syndrome, and use of PPARγ agonists is associated with heart failure. Here, mice with dilated cardiomyopathy due to cardiomyocyte PPARγ overexpression were crossed with PPARα-deficient mice. Surprisingly, this cross led to enhanced expression of several PPAR-regulated genes that mediate fatty acid (FA) uptake/oxidation and triacylglycerol (TAG) synthesis. Although FA oxidation and TAG droplet size were increased, heart function was preserved and survival improved. There was no marked decrease in cardiac levels of triglyceride or the potentially toxic lipids diacylglycerol (DAG) and ceramide. However, long-chain FA coenzyme A (LCCoA) levels were increased, and acylcarnitine content was decreased. Activation of PKCα and PKCδ, apoptosis, ROS levels, and evidence of endoplasmic reticulum stress were also reduced. Thus, partitioning of lipid to storage and oxidation can reverse cardiolipotoxicity despite increased DAG and ceramide levels, suggesting a role for other toxic intermediates such as acylcarnitines in the toxic effects of lipid accumulation in the heart.
    The Journal of clinical investigation 10/2010; 120(10):3443-54. DOI:10.1172/JCI40905 · 13.77 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: ObjectiveTo identify current clinical status of type 2 diabetic outpatients and to determine the prevalence of diabetic complications and risk factors.Material and methodProspective cross-sectional study design was used in the data collection process. The study sample consists of 1077 type 2 Diabetes Mellitus outpatients who fit the inclusion criteria. All the patients were recruited from the diabetic outpatient clinics from Hospital Universiti Sains Malaysia (HUSM). The study period was from January till December 2007. Demographic data, clinical status of diabetes and its complications were collected and analyzed for the prevalence of complications and risk factors.ResultsOne thousand and seventy seven type 2 diabetes outpatients were included in the present study. Mean age was 58.3 years and duration of diabetes was 11 years. Only 23.4% of the subjects achieved HbA1c of ⩽7%, 53.5% of patients had achieved target FPG ⩽6.7 mmol/l, and 60.4% of the patients had achieved optimal postprandial plasma glucose level <10 mmol/l. The overall prevalence of dyslipidaemia was 93.7%, hypertension was 92.7% and obesity was 81.5%. Nephropathy was the most common complication accounting for 91.0% followed by neuropathy 54.4%, retinopathy 39.3%, and macrovascular complications 17.5%. The vascular complications were significantly associated with the age (P < 0.001), BMI (P < 0.001), and triglyceride (P < 0.001).ConclusionThe prevalence of dyslipidaemia, hypertension and obesity were high. The high prevalence of vascular complications was associated with age, BMI and triglyceride of diabetic patients. Effort to treat triglyceride appropriately among elderly diabetic patients could be considered as a prime target.
    International Journal of Diabetes Mellitus 12/2010; DOI:10.1016/j.ijdm.2010.08.001